Michael Ciesielski, PhD of Roswell Park Cancer Institute gives an overview of his abstract, Circulating CD9-GFAP-survivin exosomes during active specific immunotherapy, a potential biomarker for glioma, which was presented at the American Association for Cancer Research (AACR) 2017 Annual Meeting in Washington, DC.
Abstract Overview: Vaccine Immunotherapy for Glioblastoma
